HilleVax (HLVX) to Release Quarterly Earnings on Wednesday

HilleVax (NASDAQ:HLVX - Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Wednesday, March 19th. Analysts expect HilleVax to post earnings of ($0.38) per share for the quarter.

HilleVax Stock Down 1.1 %

HLVX stock opened at $1.78 on Wednesday. HilleVax has a twelve month low of $1.55 and a twelve month high of $18.42. The company has a market cap of $88.65 million, a P/E ratio of -0.57 and a beta of 0.76. The business has a fifty day moving average of $1.91 and a 200-day moving average of $1.88.

HilleVax Company Profile

HilleVax, Inc, a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc and changed its name to HilleVax, Inc in February 2021.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.